Research Article

Proposed Models for Prediction of Mortality in Stage-I and Stage-II Gastric Cancer and 5 Years after Radical Gastrectomy

Table 1

Baseline characteristics of the patient in Groups A and B.

CharacteristicsGroup A (n = 315)Group B (n = 440)

Sex
Male238 (75.6)335 (76.1)
Female77 (24.4)105 (23.9)

Age (years)
≤60160 (50.8)257 (58.4)
>60155 (49.2)183 (41.6)

BMI
≤21.92145 (46.0)168 (38.2)
>21.92119 (37.8)272 (61.8)
Unknown51 (16.2)0

Borrmann type
020 (6.3)60 (13.6)
114 (4.4)23 (5.2)
275 (23.8)128 (29.1)
3194 (61.6)210 (47.7)
412 (3.8)19 (4.3)

Tumor location
Upper third31 (9.8)46 (10.5)
Middle third57 (18.1)53 (12.0)
Lower and entire third227 (72.1)341 (77.5)

Tumor diameter (mm)
≤50232 (73.7)337 (76.6)
>5083 (26.3)103 (23.4)

Scope of gastrectomy
Proximal gastrectomy27 (8.6)39 (8.9)
Distal gastrectomy232 (73.7)342 (77.7)
Total gastrectomy56 (17.8)59 (13.4)

Lymph node metastasis rate (%)
0153 (48.6)326 (74.1)
>0 to ≤0.3114 (36.2)108 (24.5)
>0.3 to ≤1.048 (15.2)6 (1.4)

pTNM stagea
I91 (28.9)160 (36.4)
II103 (32.7)280 (63.6)
III121 (38.4)

Histological type
Well and moderately differentiated121 (38.4)208 (47.3)
Poorly differentiated168 (53.3)180 (40.9)
Others26 (8.3)52 (11.8)

H. pylori infection
Negative43 (13.7)46 (10.5)
Positive60 (19.0)72 (16.4)
Unknown212 (67.3)322 (73.2)

aBased on the eighth edition of the AJCC Cancer Staging Manual of the American Joint Committee on Cancer.